A new neural network trained by MIT PhD student Yuzhe Yang and postdoc Yuan Yuan assesses whether or not someone has Parkinson’s from their nocturnal breathing.
Credits: Image courtesy of researchers.
An MIT-developed device with the appearance of a Wi-Fi router uses a neural network to discern the presence and severity of one of the fastest-growing neurological diseases in the world.
Parkinson’s disease is notoriously difficult to diagnose as it relies primarily on the appearance of motor symptoms such as tremors, stiffness, and slowness, but these symptoms often appear several years after the disease onset. Now, Dina Katabi, the Thuan (1990) and Nicole Pham Professor in the Department of Electrical Engineering and Computer Science (EECS) at MIT and principal investigator at MIT Jameel Clinic, and her team have developed an artificial intelligence model that can detect Parkinson’s just from reading a person’s breathing patterns.
The tool in question is a neural network, a series of connected algorithms that mimic the way a human brain works, capable of assessing whether someone has Parkinson’s from their nocturnal breathing — i.e., breathing patterns that occur while sleeping. The neural network, which was trained by MIT PhD student Yuzhe Yang and postdoc Yuan Yuan, is also able to discern the severity of someone’s Parkinson’s disease and track the progression of their disease over time.
Yang is first author on a new paper describing the work, published today in Nature Medicine. Katabi, who is also an affiliate of the MIT Computer Science and Artificial Intelligence Laboratory and director of the Center for Wireless Networks and Mobile Computing, is the senior author. They are joined by Yuan and 12 colleagues from Rutgers University, the University of Rochester Medical Center, the Mayo Clinic, Massachusetts General Hospital, and the Boston University College of Health and Rehabilition.
Over the years, researchers have investigated the potential of detecting Parkinson’s using cerebrospinal fluid and neuroimaging, but such methods are invasive, costly, and require access to specialized medical centers, making them unsuitable for frequent testing that could otherwise provide early diagnosis or continuous tracking of disease progression.
The MIT researchers demonstrated that the artificial intelligence assessment of Parkinson’s can be done every night at home while the person is asleep and without touching their body. To do so, the team developed a device with the appearance of a home Wi-Fi router, but instead of providing internet access, the device emits radio signals, analyzes their reflections off the surrounding environment, and extracts the subject’s breathing patterns without any bodily contact. The breathing signal is then fed to the neural network to assess Parkinson’s in a passive manner, and there is zero effort needed from the patient and caregiver.
“A relationship between Parkinson’s and breathing was noted as early as 1817, in the work of Dr. James Parkinson. This motivated us to consider the potential of detecting the disease from one’s breathing without looking at movements,” Katabi says. “Some medical studies have shown that respiratory symptoms manifest years before motor symptoms, meaning that breathing attributes could be promising for risk assessment prior to Parkinson’s diagnosis.”
The fastest-growing neurological disease in the world, Parkinson’s is the second-most common neurological disorder, after Alzheimer’s disease. In the United States alone, it afflicts over 1 million people and has an annual economic burden of $51.9 billion. The research team’s algorithm was tested on 7,687 individuals, including 757 Parkinson’s patients.
Katabi notes that the study has important implications for Parkinson’s drug development and clinical care. “In terms of drug development, the results can enable clinical trials with a significantly shorter duration and fewer participants, ultimately accelerating the development of new therapies. In terms of clinical care, the approach can help in the assessment of Parkinson’s patients in traditionally underserved communities, including those who live in rural areas and those with difficulty leaving home due to limited mobility or cognitive impairment,” she says.
“We’ve had no therapeutic breakthroughs this century, suggesting that our current approaches to evaluating new treatments is suboptimal,” says Ray Dorsey, a professor of neurology at the University of Rochester and Parkinson’s specialist who co-authored the paper. Dorsey adds that the study is likely one of the largest sleep studies ever conducted on Parkinson’s. “We have very limited information about manifestations of the disease in their natural environment and [Katabi’s] device allows you to get objective, real-world assessments of how people are doing at home. The analogy I like to draw [of current Parkinson’s assessments] is a street lamp at night, and what we see from the street lamp is a very small segment … [Katabi’s] entirely contactless sensor helps us illuminate the darkness.”
The Latest Updates from Bing News
Go deeper with Bing News on:
- Could dogs sniff out Parkinson’s disease?
A study now reveals more about canines’ extraordinary ability to detect human pathologies. This research focuses on Parkinson’s disease, a neurodegenerative condition characterised by the progressive ...
- Acting out dreams can signal a serious disorder
We can detect synuclein aggregates through a seeding using cerebral spinal fluid. But that would only be in people who are going to develop Parkinson's or something like Parkinson's. But a synuclein ...
- Richard Lewis dies after Parkinson's diagnosis: Early signs to spot devastating condition
Richard Lewis, known for his role on Curb Your Enthusiasm, has died at 76 a year after announcing his Parkinson's disease diagnosis.His death was confirmed by his publicist Jeff Abraham to Deadline on ...
- Pet Dogs Trained To Sniff Out Parkinson's Disease With Up To 90 Percent Accuracy
A new study reports on a years-long project that saw ordinary pets trained up to become medical detection dogs, able to sniff out the signature scent of Parkinson’s disease (PD). The study, which has ...
- Doctor Dog? Canines Can Smell Parkinson’s Disease
Trained dogs, with their remarkable sense of smell, have shown the ability to detect Parkinson’s disease with a stunning accuracy rate of nearly 90 percent. This discovery paves the way for an ...
Go deeper with Bing News on:
- NE-3107 Alzheimer’s, Parkinson’s data boost Biovie
Biovie Inc.’s double-barrelled blast of positive data with insulin sensitizer NE-3107 in Alzheimer’s disease (AD) and Parkinson’s disease (PD) launched shares (NASDAQ:BIVI) on a wild ride to close ...
- Kenai Emerges from Stealth With $82M Series A, Targets Parkinson’s
Formerly known as Ryne Bio, Kenai Therapeutics emerged on Thursday with backing from several groups and has a cell therapy candidate going after Parkinson’s disease.
- BioVie Shares Double After Positive Data for Parkinson's Disease Treatment
By Chris Wack BioVie shares doubled to $2.89 in premarket trading Friday after the company said its Phase 2A study of NE3107 suggested improvements ...
- From Pleasure to Precision: The Dual Dynamics of Dopamine in Parkinson’s Disease
Dopamine's influence extends to regulating movement lengths, offering new therapeutic targets for Parkinson's Disease. Dopamine, a chemical messenger in the brain, is mostly known for its role in how ...
- Richard Lewis once revealed 'I'm getting through it fine so far' as he battled Parkinson's disease before his death
Richard Lewis once revealed 'I'm getting through it fine so far' as he battled Parkinson's disease before his death ...